Diseases & Longevity · File 01

Multimorbidity. The metric almost nobody measures in time.

The coexistence of two or more chronic diseases in the same individual affects approximately 1 in 3 adults globally. It is not aging with one well-managed disease. It is the pattern that multiplies pain, accelerates functional decline, and rewrites the years lived without disability — years that evidence shows can be postponed.

Why the pattern matters more than each disease in isolation

Traditional medicine measures diseases one at a time. You are diagnosed with hypertension and a protocol begins; five years later type 2 diabetes appears and another protocol begins; seven years later a depressive episode shows up — and nobody connects the dots. Multimorbidity is exactly that picture: two or more chronic diseases coexisting in the same body, frequently with shared roots that preceded the first by decades.

The editorial commentary by Saurav Basu in The Lancet Healthy Longevity (2025) synthesizes the global evidence: chronic diseases account for 75% of global deaths (43 million NCD deaths in 2019), with 18 million premature deaths before age 70. And multimorbidity — not isolated disease — is the rule in older adults: the exception is aging with a single condition.

Chronic diseases rarely come alone. When two arrive, it is not coincidence — it is the same biological terrain expressing itself through different pathways.
Eriksen et al. · Scientific Reports · 2025

Adults followed for 20 years in the Danish cohort

The Diet, Cancer and Health study (Eriksen AK, Grell K, Hendriksen PF, et al., Scientific Reports 2025;15:27691) followed 57,053 Danish men and women aged 50 to 69 for 20 years. It measured the trajectory of seven major chronic diseases — cancer, type 2 diabetes, ischemic heart disease, cerebrovascular disease, asthma, COPD, and dementia — as a function of baseline health behaviors. The results on multimorbidity are the starting point of this file.

  • Life with multimorbidity

    16% vs 3% (men 65 y)

    65-year-old men with the worst health score spend 16% of their remaining life with two or more chronic diseases. With the best score, only 3%. In women: 12% vs 2.5%.

  • Years with disability

    −1.6 (M) / −3.3 (W) years

    The difference between worst and best health score translates to 1.6 fewer years with disability in men and 3.3 fewer years in women, over the 20 years after age 65.

  • Postponed diagnosis

    +7-year delay

    Among individuals with the best health scores, diagnosis of the first major chronic disease is postponed by more than 7 years compared to the worst scores.

  • Hospitalization

    2.5× more days/year

    The lowest health score predicted ~2.5 times more hospital days per year (6.1 vs 2.4 in 65-year-old men; 5.5 vs 2.5 in women) over 20 years of follow-up.

Chap. 03 · Quality of life measured with SF-36

What your PCS and MCS lose with each additional disease

The CHARLS study by Hu et al. (BMC Public Health 2024) measured health-related quality of life (HRQoL) in 13,620 Chinese adults ≥45 years using SF-36. Multivariate regression quantified the exact cost of each additional chronic disease on the questionnaire's two main components.

  • Physical component (PCS)

    β = −2.515 · p<0.01

    Each additional chronic disease reduces the SF-36 physical component by 2.515 points. Physical function, bodily pain, role-physical, and general health — all fall in measurable amounts.

  • Mental component (MCS)

    β = −0.735 · p<0.01

    Each additional chronic disease reduces the SF-36 mental component by 0.735 points. Mental health, vitality, role-emotional, and social function — the impact is smaller than physical, but cumulative.

  • Chronic pain

    Cumulative severity

    Patients with multiple conditions report more severe pain and a higher risk of depression than patients with fewer comorbidities (Ma et al. 2021, cited in CHARLS 2024).

  • Daily function (ADL)

    Accelerated disability

    The presence of chronic diseases increases the probability of developing disability in activities of daily living. In multimorbidity, that probability is non-linear: a third disease weighs more than the sum of the first two.

What we don't do — and what we do

We do not treat diseases one at a time. We do not promise to reverse what indexed evidence does not support. We do not sell cures. In established multimorbidity, structured cardiovascular disease, clinically diagnosed dementia, or cancer under treatment — all of that belongs to the organ specialist, not to a longevity clinic. And that is how it should be.

What we do: evaluate the pattern before it becomes irreversible. We measure shared axes — biological age, inflammaging, intracellular metabolic profile, microbiota, functional hormonal, toxic exposure — that are the real drivers of comorbidity accumulation. We build an individual risk map. We design a protocol under medical judgment aimed at delaying the third and fourth disease when one or two already exist.

The difference between serious longevity medicine and wellness marketing is this: we do not offer what evidence does not support, and we measure before acting.
How we measure it

The three layers of multimorbidity
risk assessment

Before talking about protocol, before proposing any intervention: we measure. The assessment of the risk of accumulating comorbidities is built from three convergent layers, not one.

Advanced biomarkers

21 specialized panels across 8 clinical categories — biological age (telomeres, DNA methylation), inflammaging, intracellular metabolic profile, functional hormonal, toxicology, microbiota. The quantitative layer of the map.

Explore →

Functional medicine

Root-cause analysis of shared drivers between apparently disconnected comorbidities. The tree of common drivers — mitochondrial dysfunction, inflammaging, neuroendocrine dysregulation — before organ pathology.

Explore →

Bioregulatory medicine

Reading of autonomic regulation, HRV, and stress response. The functional trajectory that precedes clinical diagnosis — an axis often invisible in conventional consultation.

Explore →

The Longevity Program

How multimorbidity risk assessment integrates into the full program — from initial valuation to design of an individualized protocol under medical judgment.

Explore →
Featured evidence

Three publications that quantify the real impact of multimorbidity on quality of life, disease-free life expectancy, and the global healthcare burden.

"Highest health-score individuals lived 7+ additional years without major chronic disease, and spent 3% of their remaining lifetime with multimorbidity vs 16% in the lowest-score group."
n=57,053 · 20 years · Danish cohort
Eriksen et al.
Scientific Reports · 2025
"Each additional chronic disease reduced SF-36 Physical Component Summary by −2.515 points (p<0.01) and Mental Component Summary by −0.735 points (p<0.01) in middle-aged and older adults."
n=13,620 · CHARLS China · SF-36
Hu et al.
BMC Public Health · 2024
"Chronic diseases account for 75% of global deaths. Multimorbidity affects nearly one third of adults and is associated with diminished quality of life, increased premature mortality and rising healthcare expenditure."
43M NCD deaths · 18M premature
Basu
Lancet Healthy Longev · 2025

Frequently asked questions about multimorbidity

The most recurrent questions about the coexistence of chronic diseases, their real impact measured in quality of life (SF-36) and life expectancy, the most frequent clusters, and how Wellness Care addresses the risk of accumulating comorbidities before it becomes irreversible. Answers aligned with indexed literature.

01

What is multimorbidity?

Multimorbidity is the coexistence of two or more chronic diseases in the same individual.

It affects approximately 1 in 3 adults globally, per the systematic review by Nguyen et al. (Journal of Comorbidity 2019), cited in the Lancet Healthy Longevity 2025 commentary.

It is not the same as aging with a single well-controlled condition: multimorbidity rewrites quality of life, multiplies therapeutic complexity, and shortens years lived without disability.

Basu · Lancet Healthy Longev · 2025
02

How much does multimorbidity reduce my quality of life?

The CHARLS study by Hu et al. (BMC Public Health 2024, n=13,620 Chinese adults ≥45 years) quantified that each additional chronic disease reduces:

· The SF-36 physical component (PCS) by −2.515 points (p<0.01).
· The SF-36 mental component (MCS) by −0.735 points (p<0.01).

Chronic pain is more severe, depression risk higher, and functional capacity deteriorates cumulatively, not additively.

Hu et al. · BMC Public Health · 2024
03

How many years of useful life do I lose to multimorbidity?

In the Danish Diet, Cancer and Health cohort (Eriksen et al., Scientific Reports 2025, n=57,053, 20-year follow-up):

· 65-year-old men with the worst health score: 16% of their remaining life with ≥2 chronic diseases, vs 3% in the best score.
· Women: 12% vs 2.5%.
· Additional years with disability associated: +1.6 years (men) and +3.3 years (women) in the worst score.

Eriksen et al. · Scientific Reports · 2025
04

Why does multimorbidity matter more than each disease in isolation?

For three reasons documented in the literature:

· Therapeutic interactions: treating one disease can worsen another (adverse effects, conflicting clinical decisions).
· Exponential QoL deterioration: pain is more severe and depression risk higher in patients with more comorbidities (Ma et al. 2021, cited in CHARLS 2024).
· Intensive service use: in the Danish cohort, hospital days per year increase ~2.5× between best and worst score (6.1 vs 2.4 days/year in 65-year-old men).

05

Is it possible to prevent or delay multimorbidity?

Indexed evidence supports yes, partially:

· Nyberg et al. (JAMA Internal Medicine 2020): adults with the best score of healthy habits (no smoking, healthy BMI, physical activity, diet, moderate alcohol) live 9–10 additional years without T2D, CHD, stroke, cancer, asthma, or COPD.
· Licher et al. (PLoS Medicine 2019): absence of hypertension, overweight, and smoking was associated with 9-year delay in diagnosis of non-communicable diseases.
· Basu (Lancet Healthy Longev 2025): modifiable factors explain up to 75% of chronic disease accumulation. The rest is genetic, environmental, and not yet fully measurable.

06

How is multimorbidity measured in clinical practice?

Two complementary approaches:

· Simple quantitative: count the number of diagnosed chronic diseases. CHARLS evaluated 14 conditions (hypertension, dyslipidemia, T2D, cancer, liver disease, heart problems, stroke, CKD, GI, mental health, cognitive impairment, arthritis, asthma, COPD).
· Functional: validated questionnaires like SF-36 that measure HRQoL in its two components (physical and mental), allowing trajectories to be tracked over time.

Wellness Care integrates both with quantitative biomarkers of aging — telomeres, DNA methylation, inflammaging — to anticipate trajectories before clinical diagnosis.

07

Which diseases tend to cluster as multimorbidity?

The most frequent clusters in longitudinal cohorts are:

· Cardiometabolic: hypertension + dyslipidemia + T2D + central obesity.
· Respiratory-cardiac: COPD + ischemic heart disease + heart failure.
· Neurodegenerative: dementia + depression + osteoarthritis with falls.

These clusters are not random: they share common mechanistic axes — inflammaging, mitochondrial dysfunction, endocrine dysregulation, oxidative stress — measured with advanced biomarkers before clinical disease appears.

08

How does Wellness Care approach multimorbidity?

Wellness Care does not treat diseases one at a time. We evaluate the complete pattern through an advanced biomarker panel (biological age, inflammaging, intracellular metabolic profile, microbiota, functional hormonal) and build an individual map of the risk of accumulating comorbidities.

When a person already has one or two diseases, the protocol goal is to delay or avoid the third and fourth — not to cure the incurable. That is the difference between serious longevity medicine and organ-specialized medicine.

Every clinical decision is individualized and under strict medical judgment.

The metric that matters

There are 10 years between the first signal and the diagnosis. And another 7 years between the first disease diagnosis and the arrival of the second. Those are the years evidence shows can be moved.

Measuring biomarkers before diagnosis, identifying the pattern before the cluster, intervening on what is modifiable under indexed evidence — that is serious longevity medicine. It is not preventing all diseases. It is delaying the second.

Do you have one or two chronic conditions?

Book a multimorbidity risk assessment

We evaluate clinical history, shared factors between diseases, advanced biomarker profile, and functional trajectory. If you already have one chronic condition, relevant family history, or want to understand your biological pattern before the second one arrives — this is exactly what we do.

Book assessment